Genmab — November 2020
-
Yes, very important. These numbers indicate that Sarclisa will probably never get any big marketshare
-
Spørgsmålmål til Q&A er meget velkommen.
-
Tepezza Oct Symphony $88m (+9% m/m) https://twitter.com/BioPharmaMeat/status/1331430327923961856
-
DnB: Today Genmab announced that it will not advance the
development of enapotamab vedotin (EV), citing that
the data did not meet its stringent criteria for proof-ofconcept. This confirms the company’s strategy to end
projects that are not efficacious enough and we believe
it will be likely to also scrap DR5/DR5. Genmab’s focus
is on progressing already-partnered projects. We
reiterate our HOLD but have cut our target price to
DKK2,320 (2,352). -
Indlæg fra Macabo 09:04 ("EA kind of a weak up call - Pensionisten i dere s morgen brev fra PB") forstår jeg ikke en dyt af. Lyder som en af de der noter fundet i en gammel stok eller i en begravet metalæske, som Tintin regelmæssigt prøver på at dechiffrere
Jeg efterlyser en minimal anstrengelse for at skrive noget forståeligt... -
Bibob, jeg har haft travlt til morgen og har ikke set at det allerede er postet. Troede ikke der var andre der havde adgang til DnB
-
Så er jeg med på holdet igen, tankede godt op i 2185 i går og solgte lidt i dag (for tidligt) i 2210. Kunne ikke blive ved med at vente på 2150
Fantastisk firma, fantastisk fremtid, fantastisk chef og fantastisk forum 
Skulle den ramme 2150 tanker jeg videre op der. -
Upcoming Events : https://ir.genmab.com/events-and-presentations#content
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind